Jefferies Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14,797
Closed -$590K 1672
2022
Q1
$590K Buy
14,797
+6,547
+79% +$233K ﹤0.01% 1015
2021
Q4
$332K Buy
+8,250
New +$308K ﹤0.01% 1277
2019
Q3
Sell
-47,500
Closed -$816K 2822
2019
Q2
$816K Buy
+47,500
New +$766K 0.01% 1401
2018
Q3
Sell
-10,088
Closed -$170K 2528
2018
Q2
$170K Buy
+10,088
New +$191K ﹤0.01% 2060
2018
Q1
Sell
-20,537
Closed -$416K 2430
2017
Q4
$416K Buy
20,537
+20,137
+5,034% +$370K ﹤0.01% 1825
2017
Q3
$7K Buy
+400
New +$5.42K ﹤0.01% 2270
2017
Q1
Sell
-17,511
Closed -$173K 2466
2016
Q4
$173K Buy
+17,511
New +$192K ﹤0.01% 1939
2016
Q2
Sell
-12,500
Closed -$118K 2250
2016
Q1
$118K Buy
+12,500
New +$118K ﹤0.01% 1946
2014
Q1
Sell
-86
Closed -$1K 2178
2013
Q4
$1K Sell
86
-12,880
-99% -$166K ﹤0.01% 1855
2013
Q3
$143K Buy
+12,966
New +$108K ﹤0.01% 1670

Other funds holding HALO

Jefferies Group's HALO Position: Q2 2022 in Review

Jefferies Group sold out of Halozyme (HALO) in Q2 2022, closing a stake of 14,797 shares — an estimated $590K sold.

Jefferies Group first reported a position in HALO in Q3 2013 and held it in 10 quarters. The position peaked at $816K in Q2 2019. 367 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

  • Jefferies Group reported no remaining Halozyme position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 14,797 Halozyme shares in Q2 2022, an estimated $590K.
  • Jefferies Group first reported a position in Halozyme in Q3 2013 and held it in 10 quarters.
  • Jefferies Group's Halozyme position peaked at $816K in Q2 2019.
  • 367 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.